We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Direct Reprogramming of Fibroblasts into Melanocytes Avoids Cancer Threat

By LabMedica International staff writers
Posted on 29 Dec 2014
A team of cell biologists has successfully induced fibroblasts to convert to functional melanocytes (melanin-producing skin cells) without going through a preliminary pluripotent stage.

Direct reprogramming provides a fundamentally new approach for the manufacture of patient-specific cells that greatly reduces the danger of inadvertently generating tumors. More...
In the current study, investigators at the University of Pennsylvania (Philadelphia, USA) and their colleagues devised a method for directly reprogramming fibroblasts into functional melanocytes.

The first step was to identify 10 specific cell transcription factors linked to melanocyte development. Transcription factor screening assays revealed that three transcription factors - SOX10 (sex determining region Y-box 10), MITF (microphthalmia-associated transcription factor), and PAX3 (paired box 3) - out of those 10 were sufficient to induce fibroblasts to transform into melanocytes.

Results published in the December 16, 2014, online edition of the journal Nature Communications revealed that induced melanocytes (iMels) produced by this technique activated melanocyte-specific networks, expressed components of the pigment production and delivery system, and produced melanosomes. Human iMels properly integrated into the dermal-epidermal junction and produced and delivered melanin pigment to surrounding keratinocytes in a three-dimensional organotypic skin reconstruct. Furthermore, human iMels generated pigmented epidermis and hair follicles in skin reconstitution assays in vivo.

"We did a huge amount of work," said senior author Dr. Xiaowei Xu, associate professor of pathology and laboratory medicine at the University of Pennsylvania. "We eliminated all the combinations of the other transcription factors and found that these three are essential. Through direct reprogramming, we do not have to go through the pluripotent stem cell stage, but directly convert fibroblasts to melanocytes. So these cells do not have tumorigenicity. By generating melanocytes from the fibroblasts of melanoma patients, we can screen not only to find why these patients easily develop melanoma, but possibly use their cells to screen for small compounds that can prevent melanoma from happening."

Related Links:
University of Pennsylvania


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.